AI Science Tracker
EN

Integration of Multidimensional Genetic and Single- Cell Analyses to Identify Potential Drug Targets and a Clinical Risk Prediction Model for Cervical Cancer

Affiliation not stated in the reviewed material · 28 Sep 2026 · medicine

Discovery

Integration of Multidimensional Genetic and Single- Cell Analyses to Identify Potential Drug Targets and a Clinical Risk Prediction Model for Cervical Cancer

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Integrated genetic, transcriptomic and single-cell analyses used machine-learning feature selection and Mendelian-randomization evidence to identify cervical-cancer-associated genes and candidate therapeutic targets; the preprint reports specific gene associations, not established treatment effects.

Technology: Machine-learning analysis applies the stated model to the paper’s medicine dataset and evaluates the reported outcome.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning analysis applies the stated model to the paper’s medicine dataset and evaluates the reported outcome.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.21203/rs.3.rs-10712879/v1

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.